Stock CYPROTEX PLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Cyprotex plc

Equities

GB0031214470

Biotechnology & Medical Research

End-of-day quote London S.E.
Other stock markets
- GBX - Intraday chart for Cyprotex plc
2013 Cyprotex plc : Drug testing firm Cyprotex eyes deals after raising 7 million pounds RE

Managers

Managers TitleAgeSince
Christian Dargel SEC
 Corporate Secretary - 21-04-12

Members of the board

Members of the board TitleAgeSince
Craig Johnstone BRD
 Director/Board Member 54 -
Stephen Madden BRD
 Director/Board Member - 23-03-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 22,509,042 12,087,403 ( 53.70 %) 0 53.70 %

Company contact information

Cyprotex Ltd.

114 Innovation Drive, Milton Park

OX14 4RZ, Abingdon

+

http://www.cyprotex.com
address Cyprotex plc

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. Stock
  4. Company Cyprotex plc